These outcomes, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 assist the notion of concentrating on ACKR3 as a unique technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected Ailments.Besides the described earlier mentioned